Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3

被引：0
|
作者：
Kay Tanita
Fumiaki Sakura
Ryusuke Nambu
Miyuki Tsumura
Yusuke Imanaka
Hidenori Ohnishi
Zenichiro Kato
Jie Pan
Akihiro Hoshino
Koji Suzuki
Motoko Yasutomi
Shuichiro Umetsu
Chizuru Okada
Masatoshi Takagi
Kohsuke Imai
Osamu Ohara
Alexo M. Muise
Satoshi Okada
Tomohiro Morio
Hirokazu Kanegane
机构：
[1] Graduate School of Medical and Dental Sciences,Department of Pediatrics and Developmental Biology
[2] Tokyo Medical and Dental University (TMDU),Department of Pediatrics
[3] Hiroshima University Graduate School of Biomedical and Health Sciences,Division of Gastroenterology and Hepatology
[4] Saitama Children’s Medical Center,SickKids Inflammatory Bowel Disease Center
[5] The Hospital for Sick Children,Cell Biology Program, Research Institute
[6] The Hospital for Sick Children,Department of Pediatrics
[7] Gifu University Graduate School of Medicine,Structural Medicine, United Graduate School of Drug Discovery and Medical Information Sciences
[8] Gifu University,Department of Pediatrics, Faculty of Medical Sciences
[9] University of Fukui,Department of Pediatric Hepatology and Gastroenterology
[10] Saiseikai Yokohama-shi Tobu Hospital,Department of Community Pediatrics, Perinatal and Maternal Medicine
[11] Hiroshima Chuodori Children Clinic,Department of Technology Development
[12] Graduate School of Medical and Dental Sciences,Laboratory for Integrative Genomics
[13] Tokyo Medical and Dental University (TMDU),Department of Pediatrics, Institute of Medical Science and Biochemistry
[14] Kazusa DNA Research Institute,Department of Child Health and Development
[15] RIKEN Center for Integrative Medical Sciences,undefined
[16] University of Toronto,undefined
[17] the Hospital for Sick Children,undefined
[18] Graduate School of Medical and Dental Sciences,undefined
[19] Tokyo Medical and Dental University (TMDU),undefined
来源：
Journal of Clinical Immunology | 2021年 / 41卷
关键词：
Signal transducer and activator of transcription 3; gain-of-function; heterogeneity; incomplete penetrance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：780 / 790
页数：10
相关论文
共 50 条
  • [21] GAINING MORE INSIGHT INTO STAT3 GAIN-OF-FUNCTION DISEASE: A CASE PRESENTATION
    Cherk, E.
    Dimitriades, V.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S148 - S148
  • [22] Low IgE Is a Useful Tool to Identify STAT3 Gain-of-Function Mutations
    Johnson, Matthew B.
    Flanagan, Sarah E.
    Martins, Thomas B.
    Hill, Harry R.
    Hattersley, Andrew T.
    McDonald, Timothy J.
    CLINICAL CHEMISTRY, 2016, 62 (11) : 1536 - 1538
  • [23] STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection
    Gonzalez-Mancera, Miguel S.
    Johnson, Britt
    Mirsaeidi, Mehdi
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 30
  • [24] Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
    Zheng, Jie
    de Veerdonk, Frank L. van
    Crossland, Katherine L.
    Smeekens, Sanne P.
    Chan, Chun M.
    Al Shehri, Tariq
    Abinun, Mario
    Gennery, Andrew R.
    Mann, Jelena
    Lendrem, Dennis W.
    Netea, Mihai G.
    Rowan, Andrew D.
    Lilic, Desa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (10) : 2834 - 2846
  • [25] GAIN-OF-FUNCTION STAT1 MUTATION IMPAIRS STAT3 FUNCTION PREDISPOSING TO CHRONIC MUCOCUTANEOUS CANDIDIASIS
    Zheng, Jie
    de Veerdonk, Frank van
    Crossland, Katherine
    Smeekens, Sanne P.
    Abinun, Mario
    Gennery, Andrew R.
    Mann, Jelena
    Lendrem, Dennis
    Netea, Mihai G.
    Rowan, Andrew D.
    Lilic, Desa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 704 - 704
  • [26] Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors
    Carmona, M. D. Silva
    Vogel, T.
    Marchal, S.
    Guesmi, M.
    Dubus, J.
    Baravalle, M.
    Leroy, S.
    Marquette, C.
    Fabre, A.
    Barlogis, V.
    Leiding, J.
    Forbes, L.
    Giovannini-Chami, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [27] Clinical and Immunological Features of Patients with Gain-Of-Function PIK3CD Mutations in Japan
    Takashima, T.
    Tsujita, Y.
    Yeh, T. W.
    Mitsuiki, N.
    Kanegane, H.
    Kracker, S.
    Durandy, A.
    Nonoyama, S.
    Morio, T.
    Imai, K.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S431 - S432
  • [28] STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
    Sauer, Merle
    Scheffel, Joerg
    Frischbutter, Stefan
    Mahnke, Niklas
    Maurer, Marcus
    Burmeister, Thomas
    Krause, Karoline
    Metz, Martin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation
    Parlato, Marianna
    Charbit-Henrion, Fabienne
    Elie, Abi Nader
    Begue, Bernadette
    Guegan, Nicolas
    Bruneau, Julie
    Khater, Sherine
    Macintyre, Elizabeth
    Picard, Capucine
    Frederic, Rieux-Laucat
    Le Bourhis, Lionel
    Allez, Matthieu
    Goulet, Olivier
    Cellier, Christophe
    Hermine, Olivier
    Cerf-Bensussan, Nadine
    Malamut, Georgia
    GASTROENTEROLOGY, 2019, 156 (04) : 1206 - +
  • [30] Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation
    Wang, Wenjie
    Liu, Luyao
    Hui, Xiaoying
    Wang, Ying
    Ying, Wenjing
    Zhou, Qinhua
    Hou, Jia
    Yang, Mi
    Sun, Bijun
    Sun, Jinqiao
    Wang, Xiaochuan
    BMC IMMUNOLOGY, 2021, 22 (01)
12345